Skip to main content

Find Clinical Trials

Home
Conditions
Locally Advanced Unresectable or Metastatic Gastroesophageal Junction (GEJ) Adenocarcinoma

Clinical trial condition

Locally Advanced Unresectable or Metastatic Gastroesophageal Junction (GEJ) Adenocarcinoma

Explore clinical trials studying Locally Advanced Unresectable or Metastatic Gastroesophageal Junction (GEJ) Adenocarcinoma. Study availability and eligibility vary by location and protocol.

1 public trial 1 recruiting study

Refine in advanced search Browse all conditions

Locally Advanced Unresectable or Metastatic Gastroesophageal Junction (GEJ) Adenocarcinoma trial results

Recruiting

M108 Plus CAPOX Versus Placebo Plus CAPOX as First-line Treatment for Claudin (CLDN) 18.2-Positive, HER2-Negative, PD-L1 CPS<5, Locally Advanced Unresectable or Metastatic Gastric or Gastroesophageal Junction (GEJ) Adenocarcinoma.

NCT06177041

Conditions: Adenocarcinoma, Carcinoma, Digestive System Diseases, +11 more
Locations: Beijing Cancer Hospital Beijing, Beijing Municipality, China

View Trial Details